European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ. Alfred Witjes, Antoine G. van der Heijden, Harman Max Bruins et al.|European Urology|2023Cited by 618
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Emmanouil Fokas, Lutz Jacobasch, Jürgen Weitz et al.|Journal of Clinical Oncology|2019Cited by 536
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerEmmanouil Fokas, Katica Krajinovic, Anke Schlenska‐Lange et al.|JAMA Oncology|2021Cited by 349
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G. van der Heijden, Michael Rink, Harman Max Bruins et al.|European Urology|2025Cited by 159
Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancerJens R. Laurberg, Lars Dyrskjøt, Anne Sofie Brems-Eskildsen et al.|British Journal of Urology|2012Cited by 101